Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

What’s Going On With Sigma Additive Solutions Stock?

Sigma Additive Solutions, Inc. (NASDAQ: SASI) shares are soaring higher Wednesday. The company announced the closing of the acquisition of NextTrip Holdings and a new chief executive officer.
byErica Kollmann
January 3, 2024
1 minute read
Total
0
Shares
0
0
0
0
0
0

Sigma Additive Solutions, Inc. (NASDAQ:SASI) shares are soaring higher Wednesday. The company announced the closing of the acquisition of NextTrip Holdings and a new chief executive officer. The stock was among this mornings largest movers. 

What To Know:

Sigma Additive Solutions announced that its acquisition of NextTrip closed on Dec. 29 at which time NextTrip became a wholly owned subsidiary of Sigma. Additionally, Jacob Brunsberg, former president and CEO of Sigma, resigned from such roles, and Bill Kerby, CEO of NextTrip, was appointed as the new CEO of Sigma.

On Tuesday, Sigma was granted a U.S. patent for defect detection for additive manufacturing systems.

Related News: What’s Going On With Palantir Technologies Stock?

SASI Price Action: According to Benzinga Pro, Sigma Additive Solutions shares are up 51.9% at $4.40 at the time of publication.

Image: Gerd Altmann from Pixabay

 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0
Related Posts
Read More

Gilead Announced Monday it Would Acquire Remaining Worldwide Rights of Trodelvy from Everest Medicines for $280M Upfront Plus Up to $175M in Milestones

By Charles Gross
August 16, 5:23 AM
Gilead Sciences, Inc. (Nasdaq: GILD) today announced an agreement with Everest Medicines to transfer all development and commercialization rights to Gilead for Trodelvy® (sacituzumab govitecan) in Greater China, South Korea, Singapore, Indonesia, Philippines, Vietnam, Thailand, Malaysia and Mongolia.

GILD